iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022GlobeNewsWire • 12/05/22
iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 09/27/22